378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies
Titel:
378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies
Auteur:
de Weger, V. Lolkema, M.P. Dickson, M. Le Cesne, A. Wagner, A. Merqui-Roelvink, M. Varga, A. Tap, W. Schwartz, G. Demetri, G. Zheng, W. Tuffal, G. Mace, S. Miao, H. Schellens, J.H.M. de Jonge, M.